These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16765588)

  • 1. (CA)n microsatellite polymorphism of ERBB-1 in breast cancer.
    Wełnicka-Jaśkiewicz M; Zaczek A; Brandt B; Bielawski KP; Jaśkiewicz J; Konopa K; Jassem J
    Eur J Cancer; 2006 Aug; 42(12):1698-701. PubMed ID: 16765588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.
    Buerger H; Packeisen J; Boecker A; Tidow N; Kersting C; Bielawski K; Isola J; Yatabe Y; Nakachi K; Boecker W; Brandt B
    J Pathol; 2004 May; 203(1):545-50. PubMed ID: 15095477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development.
    Tidow N; Boecker A; Schmidt H; Agelopoulos K; Boecker W; Buerger H; Brandt B
    Cancer Res; 2003 Mar; 63(6):1172-8. PubMed ID: 12649171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
    Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
    BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations associated with early stages of breast tumor metastasis.
    Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Hooke JA; Love B; Shriver CD
    Ann Surg Oncol; 2008 Jul; 15(7):1989-95. PubMed ID: 18401664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism of the mitochondrial microsatellite 303-315 in breast cancer in Tunisia].
    Yacoubi-Loueslati B; Troudi W; Baccar A; Cherni L; Rhomdhane KB; Elgaaied AB
    Bull Cancer; 2009 Mar; 96(3):337-42. PubMed ID: 19318312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic imbalance of HER2 variant in sporadic breast and ovarian cancer.
    Puputti M; Sihto H; Isola J; Butzow R; Joensuu H; Nupponen NN
    Cancer Genet Cytogenet; 2006 May; 167(1):32-8. PubMed ID: 16682283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
    Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
    Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides.
    Dialyna I; Tzanakakis G; Dolapsakis G; Tsatsakis A
    Toxicol Lett; 2004 Jun; 151(1):267-71. PubMed ID: 15177662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of sequential genetic alterations relevant for breast cancer development.
    Niederacher D; Schnürch HG; An HX; Ellenberger I; Dall P; van Roeyen CR; Küppers V; Beckmann MW
    Eur J Cancer Prev; 1996 Dec; 5(6):497-503. PubMed ID: 9061283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of allele dosage at polymorphic microsatellite loci displaying allelic imbalance in tumors by means of quantitative competitive-polymerase chain reaction.
    Sjöling A; Walentinsson A; Nordlander C; Karlsson A; Behboudi A; Samuelson E; Levan G; Röhme D
    Cancer Genet Cytogenet; 2005 Mar; 157(2):97-103. PubMed ID: 15721629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of HER2 is a marker for global genomic instability.
    Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Love B; Hooke JA; Shriver CD
    BMC Cancer; 2008 Oct; 8():297. PubMed ID: 18854030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer?
    Losanoff JE; Zhu W; Qin W; Mannello F; Sauter ER
    Breast; 2008 Oct; 17(5):540-2. PubMed ID: 18571924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A; Ulu A; Cam R; Akar N
    J BUON; 2006; 11(4):481-4. PubMed ID: 17309181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.